List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 32 studies with search of: Open Studies | "Choroidal Neovascularization"
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting TTT Versus PDT for Treatment of Choroidal Neovascularization in Age-Related Macular Degeneration
Condition: Choroidal Neovascularization
Intervention: Procedure: Photodynamic therapy versus Transpupillary thermotherapy
2 Recruiting Safety Study of Ranibizumab Eye Injections to Treat Choroidal Neovascularization That Was Caused Other Than by Age-Related Macular Degeneration.
Condition: Choroidal Neovascularization
Intervention: Drug: ranibizumab
3 Recruiting Ranibizumab to Treat CNVs in Patients With PXE
Condition: Choroidal Neovascularization
Intervention: Drug: Intravitreal injection ranibizumab
4 Recruiting Avastin for CNV Secondary to Pattern Dystrophy
Condition: Choroidal Neovascularization Secondary to Pattern Dystrophy
Intervention: Procedure: intravitreal triamcinolone injection of avastin (1.25 mg)
5 Recruiting An Open Label Trial to Investigate Macugen for the Preservation of Visual Function in Subjects With Neovascular AMD
Conditions: Age Related Macular Degeneration (AMD);   Macular Degeneration;   Choroidal Neovascularization (CNV)
Intervention: Drug: Pegaptanib Sodium 0.3 mg
6 Not yet recruiting Does Vascular Endothelial Growth Factor (VEGF) or Complement Factor H Gene Polymorphism Play a Role in the Treatment Success With VEGF Inhibitors in Patients With Choroidal NeoVascularization (CNV)?
Conditions: Choroidal Neovascularization;   Age-Related Macular Degeneration
Intervention: Genetic: VEGF genotyping
7 Recruiting Phase 1/2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Patients With Age-Related Macular Degeneration
Conditions: Age-Related Macular Degeneration;   Choroidal Neovascularization
Interventions: Drug: Sirolimus;   Drug: Sirolimus
8 Recruiting Phase 2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Combination With Lucentis® in Patients With Age-Related Macular Degeneration
Conditions: Age-Related Macular Degeneration;   Choroidal Neovascularization
Interventions: Drug: Sirolimus in combination with ranibizumab;   Drug: Sirolimus in combination with ranibizumab;   Drug: Placebo in combination with ranibizumab
9 Recruiting Safety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM) Ocular Brachytherapy System
Conditions: Macular Degeneration;   Choroidal Neovascularization
Intervention: Device: Ocular Brachytherapy
10 Recruiting Stratus Versus Cirrus OCT in AMD
Conditions: Age-Related Macular Degeneration;   Choroidal Neovascularization
Intervention:
11 Recruiting A Phase 1 Dose Escalation Study of PF-04523655 (REDD14NP) In Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (Wet AMD).
Condition: Age-Related Macular Degeneration
Intervention: Drug: PF-04523655
12 Not yet recruiting Phase II Multicenter Study For Age Related Macular Degeneration Comparing An Investigational Drug PF-04523655 Versus Lucentis In The Treatment Of Subjects With Choroidal Neovascularization (MONET Study).
Condition: Age Related Macular Degeneration
Interventions: Drug: PF-04523655;   Drug: PF-04523655;   Drug: PF-04523655;   Drug: Lucentis
13 Not yet recruiting Safety and Efficacy of a New Therapy as Adjunctive Therapy to Anti-VEGF in Subjects With Wet Age-Related Macular Degeneration
Conditions: Choroidal Neovascularization;   Age-Related Maculopathy
Intervention: Drug: Dexamethasone as adjunctive therapy to Ranibizumab Injection
14 Recruiting Evaluation of Dosing Interval of Higher Doses of Ranibizumab
Conditions: Macular Degeneration;   Choroidal Neovascularization
Intervention: Drug: ranibizumab
15 Recruiting Reduced Fluence Photodynamic Therapy (PDT) With Visudyne in Combination With Lucentis for Age-Related Macular Degeneration
Conditions: Age-Related Maculopathy;   Choroidal Neovascularization
Interventions: Drug: Ranibizumab;   Drug: Verteporfin;   Drug: Verteporfin
16 Recruiting Efficacy of Retreatments With Intravitreal Bevacizumab
Conditions: Age Related Macular Degeneration;   Choroidal Neovascularization
Intervention: Drug: Intravitreal injection of Bevacizumab
17 Recruiting Intravitreal Infliximab for Diabetic Macular Edema (DME) and Choroidal Neovascularization (CNV)
Conditions: Diabetic Retinopathy;   Macular Degeneration
Intervention: Drug: intravitreal injection of infliximab
18 Not yet recruiting Ranibizumab for Treating Submacular Vascularized Pigment Epithelial Detachments
Condition: Retinal Pigment Epithelial Detachment
Interventions: Drug: Ranibizumab;   Drug: Ranibizumab
19 Recruiting Ranibizumab and Reduced Fluence PDT for AMD
Condition: Macular Degeneration
Interventions: Drug: ranibizumab;   Drug: verteporfin
20 Recruiting A Study of Strontium90 Beta Radiation With Lucentis to Treat Age-Related Macular Degeneration
Condition: Macular Degeneration
Interventions: Device: Epi-Rad90™ Ophthalmic System;   Drug: ranibizumab

Previous Page Studies Shown (1-20) Next Page (21-32)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services